GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billion

México Noticias Noticias

GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billion
México Últimas Noticias,México Titulares
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

GlaxoSmithKline and Merck KGaA have struck an immunotherapy deal worth up to $4 billion

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

MarketWatch /  🏆 3. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionMerck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
Leer más »

Stocks making the biggest moves premarket: Viacom, Centene, Merck, Alphabet & moreStocks making the biggest moves premarket: Viacom, Centene, Merck, Alphabet & moreSome of the names on the move ahead of the open.
Leer más »

Merck named the best pharma stock by Bank of AmericaMerck named the best pharma stock by Bank of AmericaBank of America named Merck its top pick among the many U.S. pharmaceutical stocks thanks to the growing success of its key cancer drug.
Leer más »

Stocks making the biggest moves premarket: Amazon, Merck, Cigna, Honeywell & moreStocks making the biggest moves premarket: Amazon, Merck, Cigna, Honeywell & moreSome of the names on the move ahead of the open.
Leer más »

Stocks making the biggest moves midday: Amazon, Merck, Exxon Mobil & moreStocks making the biggest moves midday: Amazon, Merck, Exxon Mobil & moreThese are the stocks posting the largest moves midday Friday.
Leer más »

Merck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionMerck KGaA wins GSK for immunotherapy deal worth up to $4.2 billionGlaxoSmithKline bolstered its cancer drug development pipeline on Tuesday, agree...
Leer más »



Render Time: 2025-03-06 20:24:21